Miragene Publications: 7. Sensitivity of Protein Microarray versus ELISA Lebrun, SJ. In submission 6. Development of a Protein Microarray Library and System for Rheumatoid Arthritis Disease Marker Screening, Lebrun SJ, Petchpud WN, Tolentino M, Biotechnology and Applied Biochemistry, published as an E-publication ahead of print 5. Development of a sensitive, Colorometric Microarray Assay for Allergen-Responsive Human IgE, Accepted, The Journal of Immunological Methods Lebrun SJ, Hui A, Petchpud WN, Mclaughlin CS, Miragene, Inc. 4. Development of a Low-Cost, Colorometric Protein Array System to Measure Human Autoimmune Disease Markers PreClinica; July/Aug , 2004 Lebrun SJ, Miragene, Inc. 3. Reducing Proteomics to Practice PreClinica; Editorial, July/Aug, 2004 Lebrun SJ, Miragene, Inc 2. Development of an individual specific autoantibody (ISA) protein microarray.Biotechnology and Applied Biochemistry May, 2004 Lebrun SJ, Suquilanda E, Petchpud WN: Miragene, Inc. 1. Protein Microarrays; Chapter 7, April 2004 Chapter 7. Colorimetric Microarray Assays for Rheumatoid Arthritis using a Recombinant Proteome Library; Lebrun SJ
Upcoming Publications: Enzyme Linked Protein Microarrays: Technology, Methods and Applications (book) written by Stewart J. Lebrun, Jones and Bartlett Publishers, Inc.
Additional items of note: Miragene, Inc colorometric Protein Microarray and zeta-grip technology to be used for NIH funded grant to create a Candida Albicans Proteome library. Miragene, Inc and UC Irvine scientist Stewart J. Lebrun awarded co-PI position on NIH grant
If you would like to attend a Miragene, Inc. Technology Seminar, contact Stewart J. Lebrun (714) 701-9573 lebrun@miragene.com
Miragene, Inc. owns a number of patented technologies. These cover our substrates, chemistry, imaging system, specific arrays, drug candidates and disease markers. If you are interested in a technology partnership, contact Stewart Lebrun (714) 701-9573